| 货号 | 中文品名 | CAS No. | 别名 |
| WT-DM-C25798 | IAJD93 | | |
| WT-DM-C25799 | Z-CITCO | 2583138-04-7 | |
| WT-DM-C25800 | CL4F8-6 | 2766493-12-1 | |
| WT-DM-C25801 | IAJD249 | | |
| WT-DM-C25802 | RCB-4-8 | 2941228-91-5 | |
| WT-DM-C25803 | RAD150 | 1208070-53-4 | |
| WT-DM-C25806 | BDW568 | 335401-44-0 | |
| WT-DM-C25807 | 8-(6-Aminohexylthio)guanosine-5'-O-triphosphate (sodium salt) | | |
| WT-DM-C25810 | Epitalon (trifluoroacetate salt) | | |
| WT-DM-C25813 | A011 | C27H28N6O | |
| WT-DM-C25814 | Voclosporin | 515814-01-4 | (E)-ISA247 |
| WT-DM-C25822 | NAS-181 | 1217474-40-2 | |
| WT-DM-C25825 | N-Oleoyl-DPPE (ammonium salt) | | |
| WT-DM-C25826 | M40 (trifluoroacetate salt) | | |
| WT-DM-C25828 | N-Stearoyl-DPPE (ammonium salt) | | |
| WT-DM-C25833 | αvβ5 Integrin-IN-1 | 2615912-33-7 | αvβ5 Integrin Inhibitor 1 |
| WT-DM-C25835 | YCH1899 | C25H18BrFN6O3 | |
| WT-DM-C25837 | Lixisenatide (acetate) | | |
| WT-DM-C25840 | Orforglipron | 2212020-52-3 | LY3502970 |
| WT-DM-C25842 | MPEG(30000)-NHS ester | | |
| WT-DM-C25844 | Tirzepatide (sodium salt) | | |
| WT-DM-C25846 | 10-Chloroestra-1,4-diene-3,17-dione | 91413-55-7 | 10-chloro-1,4-Estradiene |
| WT-DM-C25848 | Fumagillol | 108102-51-8 | (?)-Fumagillol |
| WT-DM-C25856 | 8-(2-azidobenzylthio) NAD+ (sodium salt) | C28H31N10O14P2S ? Na | |
| WT-DM-C25857 | Ganoderiol F | 114567-47-4 | |
| WT-DM-C25858 | 8-(4-azidophenacylthio) NAD+ (sodium salt) | C29H31N10O15P2S ? Na | |
| WT-DM-C25859 | Ganodermanondiol | 107900-76-5 | |
| WT-DM-C25860 | 6-Fluo-10-NAD+ (sodium salt) | C50H52N9O21P2 ? Na | |
| WT-DM-C25862 | HOXB7 (8-25) (trifluoroacetate salt) | | |
| WT-DM-C25863 | SSE1806 | C21H18N2O5 | |
| WT-DM-C25864 | SP-A (196-215) (human) (trifluoroacetate salt) | C107H145N29O35 ? XCF3COOH | |
| WT-DM-C25865 | DXR Inhibitor 11a (free acid) | 2260608-07-7 | 1-Deoxy-D-Xylulose-5-phosphate Reductoisomerase Inhibitor 11a |
| WT-DM-C25866 | VnP-16 (trifluoroacetate salt) | C82H112N20O17 ? XCF3COOH | |
| WT-DM-C25868 | OP-145 (trifluoroacetate salt) | | |
| WT-DM-C25870 | PTD2 (trifluoroacetate salt) | C27H51N9O6 ? XCF3COOH | |
| WT-DM-C25872 | Tat-QFNP12 (trifluoroacetate salt) | C130H225N47O35 ? XCF3COOH | |
| WT-DM-C25876 | L-K6L9 (trifluoroacetate salt) | C90H174N22O15 ? XCF3COOH | |
| WT-DM-C25879 | BRC4wt (trifluoroacetate salt) | C81H139N23O19 ? XCF3COOH | |
| WT-DM-C25880 | (?)-α-Thujone | 546-80-5 | Thujone |
| WT-DM-C25884 | D-(?)-Tagatose | 87-81-0 | |
| WT-DM-C25888 | Strophanthidin | 66-28-4 | NSC 86078 |
| WT-DM-C25889 | ZLY28 | C29H23Cl2NO4 | |
| WT-DM-C25890 | Taraxasterol | 1059-14-9 | |
| WT-DM-C25892 | Anthraflavic Acid | 84-60-6 | 2,6-Dihydroxyanthraquinone |
| WT-DM-C25894 | Silydianin | 29782-68-1 | Silidianin |
| WT-DM-C25896 | Syringetin | 4423-37-4 | Myricetin-3',5'-dimethyl ether |
| WT-DM-C25897 | Hyperoxidized Peroxiredoxin-3 Polyclonal Antibody | A hyperoxidized human Prx3 peptide sequence | |
| WT-DM-C25898 | AP-1 | C39H40ClN9O8S | |
| WT-DM-C25899 | 5-O-Methylvisammioside | 84272-85-5 | 4′-O-β-D-glucosyl-5-O-Methylvisamminol |
| WT-DM-C25901 | Chonglou Saponin VII | 68124-04-9 | Paris Saponin VII |
| WT-DM-C25902 | Soluble Epoxide Hydrolase PROTAC 1a | | |
| WT-DM-C25903 | Benzydamine (hydrochloride) | 132-69-4 | |
| WT-DM-C25904 | Chlorphenesin Carbamate | 886-74-8 | Maolate |
| WT-DM-C25905 | Tauro-Obeticholic Acid (sodium salt) | 2278141-79-8 | Obeticholic Acid Taurine Conjugate |
| WT-DM-C25906 | Mogrol | 88930-15-8 | |
| WT-DM-C25908 | ST1936 | 1210-81-7 | |
| WT-DM-C25909 | (R)-2-(3-(2-Ethoxyphenoxy)piperidin-1-yl)pyrimidine-5-carboxylic Acid | 1809064-89-8 | |
| WT-DM-C25911 | L-Arabinitol | | |
| WT-DM-C25912 | Ipamorelin (acetate) | | |
| WT-DM-C25916 | 5,7,3',4',5'-Pentamethoxyflavone | 53350-26-8 | 3’,4’,5’,5,7-Pentamethoxyflavone |
| WT-DM-C25917 | Homosildenafil | 642928-07-2 | Methylsidenafil |
| WT-DM-C25918 | Desacetylcinobufagin | 4026-95-3 | Deacetylcinobufagin |
| WT-DM-C25919 | ABD-F | 91366-65-3 | |
| WT-DM-C25922 | Juglanin | 5041-67-8 | Kaempferol-3-O-arabinofuranose |
| WT-DM-C25923 | Metixene (hydrochloride hydrate) | 7081-40-5 | Methixine |
| WT-DM-C25924 | Bactobolamine | 78013-07-7 | |
| WT-DM-C25927 | S1PL-IN-31 | 1538574-95-6 | Sphingosine-1-Phosphate Lyase Inhibitor 31 |
| WT-DM-C25928 | Notopterol | 88206-46-6 | |
| WT-DM-C25929 | Naloxone benzoylhydrazone | 119630-94-3 | |
| WT-DM-C25930 | 2-n-Dodecylfuran | 75308-12-2 | |
| WT-DM-C25931 | BTS-54-505 (hydrochloride) | 84484-78-6 | |
| WT-DM-C25933 | BNTX (maleate) | 864461-31-4 | 7-Benzylidenenaltrexone |
| WT-DM-C25934 | 4-(3,4-Difluorobenzo)curcumin | 1170354-22-9 | CDF |
| WT-DM-C25935 | CYY292 | 2644673-04-9 | |
| WT-DM-C25937 | LB244 | C29H25N5O5 | |
| WT-DM-C25938 | Cysteinyl Leukotriene Affinity Sorbent | | |
| WT-DM-C25939 | XY-4 | 474329-47-0 | |
| WT-DM-C25940 | JPC0323 Oleate | 1612785-68-8 | |
| WT-DM-C25941 | Spirapril (hydrochloride) | 94841-17-5 | SCH 33844 |
| WT-DM-C25942 | GYKI 53655 | 143692-48-2 | LY300168 |
| WT-DM-C25946 | HR68 | 2454582-64-8 | PP21 |
| WT-DM-C25947 | 244cis | 2956402-64-3 | |
| WT-DM-C25948 | Mitraciliatine | 14509-92-3 | |
| WT-DM-C25949 | Katacalcin (trifluoroacetate salt) | | |
| WT-DM-C25950 | Baccatin VI | 57672-79-4 | |
| WT-DM-C25951 | VL422 | 2765519-47-7 | |
| WT-DM-C25952 | Glutaminase C Inhibitor 11 | C24H23N7O2S | |
| WT-DM-C25960 | Bio-Ben | | |
| WT-DM-C25961 | Ipsapirone | 95847-70-4 | |
| WT-DM-C25962 | Staining Supplement (100X) | | |
| WT-DM-C25965 | WDR5-MYC Probe 12 | C25H18F3N3O4S | |
| WT-DM-C25966 | TDI-11861 | 2857049-72-8 | |
| WT-DM-C25967 | DXR Inhibitor 11a (sodium salt) | | |
| WT-DM-C25968 | Griselimycin | 26034-16-2 | NSC 246122 |
| WT-DM-C25970 | FerroLOXIN-1 | 2773428-48-9 | |
| WT-DM-C25971 | C12-113 | 1220890-27-6 | |
| WT-DM-C25972 | icFSP1 (trifluoroacetate salt) | C26H25N3O5 ? CF3COOH | |
| WT-DM-C25974 | SLU-10482 | 2755451-45-5 | |
| WT-DM-C25975 | (S)-5-hydroxy-6-methoxy Duloxetine (maleate) | C19H21NO3S ? C4H4O4 | |
| WT-DM-C25976 | C-02 | C32H28Cl2N6O5 | |
| WT-DM-C25980 | Sulfonadyn-47 | C22H23BrN2O2S | |
| WT-DM-C25981 | 33-BCRP Inhibitor | | |
| WT-DM-C25982 | CT3 | 2403729-27-9 | Cyanotriazole 3 |
| WT-DM-C25983 | SLB1122168 | C22H35N3O ? HCl | |
| WT-DM-C25984 | C18 | 2922824-09-5 | |
| WT-DM-C25985 | Europium W1024 ITC | 1204652-02-7 | |
| WT-DM-C25988 | 4A7C-301-Nurr1 Agonist | | |
| WT-DM-C25989 | Transglutaminase Assay Substrate 2 | | |
| WT-DM-C25990 | 11-A-M | 2408140-60-1 | |
| WT-DM-C25991 | Transglutaminase Assay Stop Solution | | |
| WT-DM-C25992 | MTDB | 1063592-32-4 | |
| WT-DM-C25993 | Transglutaminase Assay Positive Control | | |
| WT-DM-C25994 | NPD-2975 | C14H13FN4O | |
| WT-DM-C25998 | J27644 | C16H12ClN3O4 | |
| WT-DM-C26000 | SPE Cartridges (Phenyl) | | |
| WT-DM-C26001 | JPC0323 | 5972-45-2 | |
| WT-DM-C26003 | Collagen Standard | | |
| WT-DM-C26004 | 4-Methoxycinnamic Acid | 830-09-1 | NSC 5303 |
| WT-DM-C26005 | Gentamicin-HRP Tracer (6X) | | |
| WT-DM-C26007 | Monascin | 21516-68-7 | |
| WT-DM-C26008 | (±)-Oxomemazine | 3689-50-7 | RP 6847 |
| WT-DM-C26009 | 852A | 532959-63-0 | PF-4878691 |
| WT-DM-C26010 | CL097 | 1026249-18-2 | |
| WT-DM-C26011 | ABX-464 | 1258453-75-6 | |
| WT-DM-C26012 | pNPP Tablets | | |
| WT-DM-C26013 | DSRM-3716 | 58142-99-7 | |
| WT-DM-C26017 | Valerenic Acid | 3569-10-6 | |
| WT-DM-C26019 | De-Boc-Cabazitaxel | 1638286-64-2 | Cabazitaxel Impurity IV |
| WT-DM-C26020 | Nifuratel | 4936-47-4 | Methylmercadone |
| WT-DM-C26021 | PFI-90 | 53995-62-3 | |
| WT-DM-C26023 | 8(4'-bromophenyl)-1,3,5,7-tetramethyl-BODIPY | 850534-66-6 | |
| WT-DM-C26024 | Mandipropamid | 374726-62-2 | |
| WT-DM-C26025 | eIF2α Activator 2 | 1501618-04-7 | Eukaryotic Translation Initiation Factor 2 Subunit 1 Activator 2 |
| WT-DM-C26026 | Azaribine | 2169-64-4 | 6-Azauridine Triacetate |
